Circadian Biology, ipRGCs, and Neuroprotection in Glaucoma

This audio article is from VisualFieldTest.com.Read the full article here: https://visualfieldtest.com/en/circadian-biology-iprgcs-and-neuroprotection-in-glaucomaTest your visual field online: https://visualfieldtest.comExcerpt:Understanding Light, the Body Clock, and GlaucomaOur eyes do more than just see. Tiny retinal cells called intrinsically photosensitive retinal ganglion cells (ipRGCs) use a special pigment (melanopsin) to detect light – especially blue daylight – and send signals to the brain’s “master clock” (the suprachiasmatic nucleus). This alignment keeps our circadian rhythms on track, regulating sleep, hormone release, and other daily cycles () (). In glaucoma, these retinal ganglion cells are damaged. As they die off, the clock’s light signals weaken, often leading to circadian disruption and poor sleep (for example, glaucoma patients commonly report daytime sleepiness and fragmented nights) () (). In simple terms: because glaucoma hurts the very cells that tell our body when to wake and sleep, a vicious cycle can start where bad sleep and disrupted rhythms may further stress eye health. This article explores how ipRGC loss and circadian problems intertwine with glaucoma, and looks at emerging strategies – melatonin supplements, bright light therapy, and timing treatments – to protect vision and improve sleep. We’ll also discuss tools like sleep trackers and pupil tests researchers use, and what studies are still needed to prove these ideas.How ipRGCs Connect Light and the Body ClockMost light-sensing in the eye happens in rods and cones, which form images. But ipRGCs are a unique group of retinal ganglion cells that look for daily light signals, not detailed pictures. They contain melanopsin, which maximally absorbs blue wavelengths (~480 nm) () (). When ipRGCs detect brightness (especially morning light), they send a steady signal to the brain’s clock. That signal resets and aligns the circadian rhythm (our internal 24-hour cycle) with the outside world () (). Because ipRGCs also help control the pupil reflex and mood, they link the eyes and brain in non-visual ways. In glaucoma, ipRGCs are not immune to damage. Studies have shown people with glaucoma have fewer or less healthy ipRGCs (), which means light cues to the clock weaken. Indeed, one research review noted that even early glaucoma causes ipRGC dysfunction, reducing light input to the circadian clock (). As these cells decline, patients often experience sleep and mood changes that go beyond aging alone.Glaucoma’s Impact on Sleep and Circadian RhythmsGlaucoma doesn’t just steal vision; it can steal restful nights. Several studies find that glaucoma patients report more sleep problems than peers without glaucoma. For example, one study found glaucoma patients scored higher on daytime sleepiness scales, and this sleepiness was linked to abnormal pupil light responses (a sign of ipRGC loss) (). Other reports show glaucoma patients tend to have shorter or more fragmented sleep at night and feel unusually sleepy by day compared to healthy people () (). In large surveys, people with glaucoma were more likely to report insomnia and reduced sleep quality. For instance, a cross-sectional study of over 6,700 individuals found glaucoma was associated with very long or disrupted sleep durations (). Another found glaucoma patients went to bed later, woke up earlier or more often, and had worse overall sleep efficiency than those without eye disease (). Why? Normally, bright daytime light (especially blue light) suppresses melatonin (our “sleep hormone”) and strengthens the clock signals. But with ipRGC damage, loud light cues aren’t registered properly. Laboratory tests reveal that in early glaucoma models, blue light fails to lower nighttime Support the show